Murine Cytomegalovirus DNA in Peripheral Blood of Latently Infected Mice Is Detectable Only in Monocytes and Polymorphonuclear Leukocytes  by Mitchell, Bradley M. et al.
VIROLOGY 223, 198–207 (1996)
ARTICLE NO. 0468
Murine Cytomegalovirus DNA in Peripheral Blood of Latently Infected Mice Is Detectable Only
in Monocytes and Polymorphonuclear Leukocytes
BRADLEY M. MITCHELL, ALBERT LEUNG, and JACK G. STEVENS1
Department of Microbiology and Immunology, University of California, Los Angeles, School of Medicine, Los Angeles, California 90024-1747
Received April 10, 1996; accepted July 8, 1996
Cytomegalovirus (CMV), as do other herpesviruses, establishes a lifelong latent infection in its natural host. While in
immunologically intact hosts most CMV infections are subclinical, clinical disease follows severe immunosuppression and
immunodeficiency. In these situations CMV may produce serious life-threatening disease, and virus reactivated from the
latent state is often responsible. Essential to understanding this virus and its pathogenesis is the need to define particular
tissue and cell types harboring viral DNA. We searched for viral DNA and RNA in subpopulations of blood cells from mice
latently infected with murine CMV by using differential centrifugation and fluorescent antibody cell sorting followed by
polymerase chain reaction analysis. Following intravenous inoculation, the viral DNA was found to be present in the buffy
coat at and after 21 days postinfection, and both granulocytes and peripheral blood mononuclear leukocytes (PBML) were
reservoirs. Further analysis of the PBML fraction by separation into Mac-1/ and Mac-10 cells revealed that monocytes
harbored the DNA while lymphocytes were not sites of persistence. We conclude that in buffy coat of latently infected mice
the viral DNA is present only in cells of the myeloid lineage. The relationship of this DNA to the latent infection is discussed.
q 1996 Academic Press, Inc.
INTRODUCTION process. A central issue is the need to define the particu-
lar tissue and cell types in which the viral DNA persists.
Persistent viral infections, which include both latent
With respect to the blood/vascular system, correlation
and chronic active infections, are common, and cytomeg-
between peripheral blood transfusion and human CMV
alovirus (CMV) is one such infection receiving attention
(HCMV) transmission has been long noted (Adler, 1983;because of its relationship to immunosuppressive states.
Cheung and Lang, 1977; Winston et al., 1980). In moreAlthough most CMV infections are subclinical, clinical
defining studies, peripheral blood mononuclear leuko-disease is frequently associated with severe immuno-
cytes (PBML) have been extensively evaluated and aresuppression, especially in settings of allograft trans-
suspected both of disseminating virus and of harboringplantation (Fiala et al., 1975; Smyth et al., 1991), multiple
the latent viral genome (Bale and O’Neil, 1989; Brautigamblood transfusions (Adler, 1983), immunosuppressive
et al., 1979; Collins et al., 1994; Jordan and Mar, 1982;drug treatment of patients with terminal leukemias (Mayo
Schrier et al., 1985; Stannier et al., 1989; Stoddart et al.,and Rapp, 1980) and lymphomas (Duwall et al., 1966),
1994; Taylor-Wiedman et al., 1991). However, discrepanc-and more recently in those with acquired immunodefi-
ies exist between the various studies regarding the par-ciency syndrome (Jacobson and Mills, 1988; Hirsch,
ticular subsets of cells involved. In addition, while the1991). In these immunosuppressed and immunocom-
PBML fraction of blood has been the object of consider-promised individuals, CMV may result in serious life-
able study, analysis of polymorphonuclear leukocytesthreatening disease and in many, if not most, instances
(PBML) for CMV persistence has received only limitedthe disease results from replication and dissemination
attention (Taylor-Wiedeman et al., 1993). HCMV has beenof a persistent virus, which may have previously been
detected during acute infection in the PMNL fraction oflatent.
peripheral blood of both immunocompetent and immuno-Since ‘‘reactivated’’ CMV is a significant cause of dis-
compromised patients (Rinaldo et al., 1977; Saltzman etease, an understanding of the latent state is essential in
al., 1988; Dankner et al., 1990; Gerna et al., 1991; Revellodevelopment of any strategy to prevent or control the
et al., 1992), and murine CMV (MCMV) and MCMV DNA
have been detected in the PMNL fractions during acute
1 To whom correspondence and reprint requests should be ad- infections of mice (Collins et al., 1994). There is also
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1991; Revello et al., 1992). In addition, persistent CMV (w/v) homogenate of submandibular salivary gland tissue
in Eagle’s minimal essential medium (MEM) 12 days p.i.DNA has been detected in myeloid bone marrow cells
that serve as progenitors for both peripheral blood granu-
Infection of mice, collection of blood, and titration oflocytes and monocytes (Kondo et al., 1994). Although
virusthese results suggest that blood PMNL and their precur-
sors may undergo acute and latent CMV infection, results
For both the experimental animals and the production
from one study of persistent HCMV (Taylor-Wiedeman et
of viral stocks, female BALB/c ByJ mice 6–8 weeks of
al., 1993) indicated that PMNL do not harbor HCMV DNA.
age were infected by injection into the tail vein with 1–
The focus of the work presented here was the system-
5 1 104 plaque-forming units (PFU) of MCMV, which was
atic identification of the cell types in blood in which the
sufficient to kill approximately 10% of the animals. Blood
CMV genome persists in the latently infected hosts. For
was collected from mice by bleeding from the axillary
ease in experimental manipulation, and since the system
plexus (Donovan and Brown, 1991) and treated with 0.1
appears to closely resemble its human counterpart, we
ml of heparin (1000 units/ml in ddH2O; Sigma, St. Louis,used the murine virus (MCMV) in its natural host. The
MO). The whole-blood samples and the subsequent frac-
fact that virus would still be replicating in some tissues
tions were quantitated by hemacytometer counts and
3 weeks postinfection has been well documented in the
also analyzed qualitatively for both viability and purity.
literature and this includes work by our group. As a mat-
Cell viability was determined using trypan blue exclusion
ter of fact, since we have recently shown that persistent
staining while purity was determined by microscopic dif-
MCMV exists simultaneously in both chronic active and
ferential counts of Giemsa-stained smears. Whole blood
latent states and that the chronic active infection in the
from 29 mice was evaluated for quantity and quality. Viral
lung may persist indefinitely (Yuhasz et al., 1994), it is
stocks were titrated on MEF monolayers with an overlay
unlikely that the virus is ever completely latent in an
of MEM plus 10% fetal calf serum plus 0.2% agarose
infected animal. However, we found here that by 21 days
(Henson et al., 1966; Shanley et al., 1979).
postinfection viral RNA could no longer be detected, indi-
cating the resolution of acute infection in the blood. For Gradient fractionation of cell populations
the purpose of discussion, this is the condition to which
we refer as latently infected even though the virus may Preparation of buffy coat containing all leukocyte sub-
populations was performed by layering heparinizednot be latent at other anatomical locations. Using differ-
ential centrifugation followed by quantitative PCR analy- whole blood obtained from individual mice onto 5-ml gra-
dients of Ficoll–Paque (Pharmacia). The loaded gradi-sis, we found that both PBML and PMNL harbored the
persistent MCMV genome. Additional subfractionation of ents were allowed to sit undisturbed for 90 min at room
temperature and then the entire gradient down to, butthe PBML fraction into monocytes and lymphocytes by
fluorescent antibody cell sorting (FACS) revealed that excluding, the erythrocyte pellet was collected into fresh
tubes. The Ficoll–Paque was diluted by adjusting theMCMV DNA was detectable only in the monocyte frac-
tion; lymphocytes were not involved. Since monocytes sample volume to 15 ml with sterile PBS and mixed thor-
oughly, and buffy-coat cells were pelleted by centrifuga-and PMNL are both phagocytic scavengers, the possibil-
ity that the DNA detected was due to phagocytosis of tion at 450 g, 8 min, 18–207. Contaminating erythrocytes
were removed by a single treatment of 0.83% NH4Cl andvirus or viral DNA which is not maintained latently is
suggested. Although this possibility could not be ruled the cells were washed twice with MEM. The final pellets
from 13 animals were quantitatively and qualitatively ana-out, our reasons for favoring a latent infection of these
cells are discussed. lyzed. Other samples were further fractionated by addi-
tional differential centrifugation or fluorescent-activated
cell sorting, or frozen and stored at 0707 for PCR analy-MATERIALS AND METHODS
sis. The buffy coat prepared from whole blood [5.1 1 106
Tissue culture and virus strains { 2.5 ({SD) nucleated cells/mouse] yielded 2.2 1 106
{ 1.6 cells with approximately equal numbers of PMNLPrimary mouse embryo fibroblasts (MEF) used for viral
titrations and production of viral RNA were prepared from (44 { 11%) and PBML (56 { 11%).
Buffy coat prepared as just described was separated18- to 20-day gestation BALB/c ByJ mouse embryos (Jack-
son Laboratories, Bar Harbor, ME) and maintained as into PMNL and PBML fractions using a second Ficoll–
Paque gradient. These gradient separations were per-previously described (Thompson and Stevens, 1983). The
Smith strain of MCMV (American Type Culture Collection, formed essentially as described by the manufacturer and
the mononuclear cells were recovered from the interfaceRockville, MD) used in these studies was maintained by
serial passage in mice (Jordan et al., 1977). In general, while the PMNL were isolated by diluting the remaining
gradient and pelleting the cells as described for the buffyfemale BALB/c ByJ mice 6 –8 weeks of age were infected
by tail vein injection and viral stocks prepared as a 10% coat preparation. Both fractions were washed with MEM
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as described above. This protocol provided 1.1 1 105 { HCl, pH 8.3; 16.6 mM (NH4)2SO4 ; 20–22 pmol of each of
the primers; 185 mg/ml bovine serum albumin; 1 mCi9.4 PBML with a 94 { 4% purity and 2.3 1 105 { 2.6
PMNL with a purity of 86 { 5% (10 samples quantitated [32P]dATP; 250 mM each cold deoxynucleotide; 2.5 units
Taq polymerase (Perkin–Elmer Cetus, Norwalk, CT) andand qualitated).
An alternative method for recovery of PBML involved 5 mM MgCl2 . The samples were processed in a thermal
cycler (Ericomp, Inc., San Diego, CA). The first cycle con-loading whole blood onto Ficoll–Paque gradients and
processing as described by the manufacturer. In general, sisted of 3 min each at 94, 68, and 727 followed by 30
cycles at the same temperatures for 1 min each. Theheparinized whole blood was diluted with PBS and
loaded onto 5-ml gradients of Ficoll–Paque and centri- sample volume was adjusted to 100 ml with TE buffer,
extracted with chloroform:isoamyl alcohol (24:1), and pre-fuged (450 g, 3 min, 207). The cell band at the interface
was collected and washed as described above for the cipitated. Thirty percent of the product was electropho-
resed on a nondenaturing 5% polyacrylamide gel (29:1isolation of PMNL and PBML fractions. When this alterna-
tive procedure was used, the PBML at the interface were acrylamide:bis-acrylamide) and the gel was dried and
exposed to X-ray film with intensifying screens.the only cells collected and yielded 5.6 1 105 { 4.9 cells
with a 99.6 { 0.2% purity (six samples quantitated and For both ie-1 and APRT RT-PCR, one-tenth (10 ml) of
the final reverse transcription reaction mixture was usedqualitated).
as template as described for the ie-1 DNA except 2.5
Fluorescent-activated cell sorting mM MgCl2 was used for the APRT RT-PCR along with 1
cycle of 3 min each at 94, 55, and 727 followed by 30Lymphocyte–monocyte-enriched samples were ob-
cycles at the same temperatures for 1 min each. APRTtained using the alternative method for recovery of PBML
DNA was amplified by PCR as described for ie-1 DNAas described above, pooled (three mice/sample), and
except 2.5 mM MgCl2 was used.sorted by FACS on a FACScan Plus (Becton–Dickinson,
The first DNA PCR or RT-PCR amplification of samplesMountain View, CA) made available through the Univer-
analyzed for ie-1 DNA or RNA by double PCR was assity of California, Los Angeles, Flow Cytometery Core
described above except the radiolabeled nucleotide wasFacility Laboratory. FITC-conjugated anti-mouse Mac-1
omitted. Following chloroform:isoamyl alcohol extraction,(rat IgG2b anti-CD11b) mAb (PharMingen, San Diego, CA)
10% of the product of the first reaction (10 ml) was addedwas diluted 1:100 and used to stain the PBML cells
to a second reaction including the radiolabeled nucleo-(Mitchell and Stevens, 1996). The specificity of binding
tide. Confirmation of PCR product specificity by Southernof the Ab was controlled with a FITC-conjugated rat IgG2b
blotting for the ie-1 primers has been previously de-isotype control (1:50; PharMingen).
scribed (Yuhasz et al., 1994).
Autoradiographs of PCRs were scanned using TWAINDNA and RNA extraction
technology with a Logitech ScanMan Color scanner and
Extraction of both DNA and RNA from individual sam- FotoTouch color imaging editing software, Version 1.1
ples of buffy coat and subsequent fractions was per- (Logitech, Inc., Fremont, CA). The scanned images were
formed using TRIzol Reagent (Gibco BRL, Gaithersburg, analyzed with SigmaGel gel analysis software (Jandel
MD) as suggested by the manufacturer except as noted Corp., San Rafael, CA) and compared as previously de-
below. The DNA pellets were incubated 5 min, 567; 30 scribed (Yuhasz et al., 1994) to standard curves of ampli-
min, 377 in 8 mM NaOH to facilitate resuspension of the fied plasmid DNA containing the MCMV EcoRI fragment
DNA, and the final DNA samples were extracted once E (Mercer et al., 1983) or amplified cDNA from RNA pro-
with phenol:chloroform:isoamyl alcohol (25:24:1). DNA duced according to the manufacturer’s directions (Stra-
and RNA were precipitated with ethanol and sodium tagene, La Jolla, CA) from a Bluescript plasmid containing
chloride using glycogen as carrier. The final DNA and the MCMV HindIII L fragment (Mercer et al., 1983).
RNA samples were resuspended in ddH2O.
RESULTS
Reverse transcription and polymerase chain reactions
Detection of MCMV ie-1 DNA and RNA in buffy coat
RNA samples were reverse transcribed to produce
of mice acutely infected
cDNA templates for RT-PCR amplification as previously
described (Yuhasz et al., 1994) using pd(N)6 primers. To assess our ability to detect MCMV DNA and RNA
in samples, blood was collected from infected and mock-Primers used for amplification of the MCMV immediate
early-1 (ie-1) gene and the mouse adenine phosphoribo- infected mice 3 days p.i. and the DNA and RNA were
separately extracted from samples obtained from individ-syltransferase (APRT) gene have been previously de-
scribed (Yuhasz et al., 1994). For ie-1 DNA PCR, 20% ual mice. The DNA and RNA samples from three mice/
group in each of three independent experiments wereof the extracted DNA from each sample analyzed was
incubated in a 50-ml reaction containing 67 mM Tris – analyzed by PCR and RT-PCR, respectively. The primers
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FIG. 1. MCMV ie-1 DNA and RNA in buffy coat of acutely infected mice. Buffy-coat cells were collected from individual mock-infected mice and
mice infected for 3 days with MCMV. The DNA and RNA were extracted and analyzed by PCR and RT-PCR, respectively. Primers specific for the
MCMV ie-1 gene and transcript differentially amplify DNA (476 bp) and RNA (257 bp). Positive DNA controls included serial dilutions of pRE1, a
plasmid containing the relevant region of MCMV DNA (104, 103, 102, and 101 copies), and positive RNA controls consisted of RNA extracted from
tissue culture cells infected with MCMV. Primers specific for the murine APRT were used as internal sample controls for both DNA and RNA
amplification. Further details are presented under Materials and Methods.
chosen to detect MCMV ie-1 DNA and RNA transcribed 1 106 to 1.1 1 107 cells), the levels in mock-infected
mice were not less than those in infected animals.from the ie-1 gene have been previously described (Yu-
hasz et al., 1994). These can be used to differentiate PCR
products derived from DNA and RNA by product size Analysis of buffy coat from latently infected mice for
with the PCR product originating from viral DNA being MCMV ie-1 DNA and RNA
476 bp, while the product of cDNA derived from the mes-
senger RNA is 257 bp (Keil et al., 1987). As can be seen Having established our ability to detect both viral DNA
and viral RNA in blood samples from acutely infectedin Fig. 1, both ie-1 DNA and ie-1 RNA were readily de-
tected in the buffy coat of mice acutely infected with mice, we looked for viral DNA and RNA in latently in-
fected mice. Blood was collected from infected andMCMV, but not those mock infected. The amounts of
DNA and RNA were well above our lower limits of detec- mock-infected mice 21 days p.i., and the DNA and RNA
were separately extracted from each individual sampletion of 102 copies each as determined by PCR and RT-
PCR analysis of plasmid DNA and in vitro-transcribed as for the acutely infected samples and analyzed by PCR
and RT-PCR. The results presented in Fig. 2 are repre-RNA, respectively (data not shown). As another RT-PCR
control, a sample of RNA extracted from MCMV-infected sentative of the buffy-coat samples from four indepen-
dent experiments. As with the samples from acutely in-MEF cells was included in the reverse transcription and
subsequent RT-PCR amplification (Fig. 1). To establish fected mice, MCMV ie-1 DNA was easily detected in
samples from MCMV-infected mice 21 days p.i. and ab-efficiency of extraction and amplification, a pair of prim-
ers homologous to sequences in the mouse APRT gene sent in samples from mock-infected mice. However,
MCMV ie-1 RNA was not detected in any of the samples(Dush et al., 1985) was used to amplify relevant se-
quences. As with the ie-1 primers, APRT DNA- and RNA- tested by RT-PCR, suggesting that the DNA was in a
latent state. As described under Materials and Methods,derived PCR products could be differentiated by size (374
and 186 bp, respectively). While there was some variation negative RT-PCR samples were further confirmed to be
negative by using double PCR, a technique which in-in the APRT signals between and within individual
groups, which would be expected since the number of creased our level of sensitivity to less than 10 template
copies per sample (data not shown). Finally, the DNAcells recovered in individual samples varied (range 2.3
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FIG. 2. MCMV ie-1 DNA and RNA in buffy coat of latently infected mice. Buffy-coat cells were collected from mock-infected mice and mice
infected for 21 days with MCMV. The DNA and RNA were extracted and analyzed by PCR and RT-PCR, respectively, as described in the legend
for Fig. 1.
PCR and the RT-PCR for mouse APRT indicated that there described under Materials and Methods for recovery of
PBML. This resulted in a ca. 5.1-fold increase in thewere no differences in extractions and amplifications.
number of cells and an increase in purity of PBML from
Analysis of PBML and PMNL fractions from latently 94% using the ‘‘original’’ fractionation to 99.6%. The DNA
infected mice for MCMV ie-1 DNA and RNA and RNA were extracted from PBML fractions processed
from latently infected mice (21 days p.i.) in three indepen-After determining that MCMV DNA persists in the buffy
dent experiments (three mice/group) and analyzed bycoat of mice, we began to define cell population(s) within
PCR for MCMV ie-1 DNA and mouse APRT DNA. Figurethe buffy coat which harbor the persisting MCMV ge-
4 shows the results of the DNA PCR amplification ofnome. Initially, in four independent experiments, buffy
the PBML fractions isolated by the alternative method incoat cells of latently infected or mock-infected mice
comparison to PBML fractions isolated by the original(three mice/group) were fractionated using Ficoll–Paque
method. Based upon densitometric scans of autoradio-gradients into PBML and PMNL as matched sets. The
graphs, the relative signal intensity for ie-1 DNA from theDNA and RNA were extracted from each individual frac-
alternative method fractions increased 4.4-fold with antion and analyzed for MCMV ie-1 DNA and ie-1 RNA. As
average 3.7-fold increase in APRT DNA signal.shown in Fig. 3A, the majority of the signal for the MCMV
DNA in latently infected mice was detected in the PMNL
Analysis of lymphocyte and monocyte fractions from
fraction. However, positive signals for ie-1 DNA were
latently infected mice for MCMV ie-1 DNA
also found in the PBML fraction although at reduced
levels compared to the PMNL fraction. RT-PCR of all The previous studies determined that PMNL and
PBML fractions both contained cells positive for persis-samples showed no ie-1 signal for RNA (Fig. 3B) and
remained negative upon double PCR analysis (data not tent MCMV DNA. The less intense signal in the PBML
fraction indicated that only a small percentage or a sub-shown). APRT signals for both DNA PCR and RT-PCR
were comparable for all samples. population of cells in that fraction was responsible for
harboring the DNA. We sought to further define the cellTo confirm that the signal in the PBML fraction was
legitimate and not due to contaminating PMNL or other type(s) involved by additional fractionation of the PBML
using FACS. PBML cells were obtained in three indepen-non-PBML cells (£6%), we used the ‘‘alternative’’ method
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FIG. 3. MCMV ie-1 DNA and RNA in PBML and PMNL cell fractions of latently infected mice. Buffy-coat cells were collected from mock-infected
mice and mice infected for 21 days with MCMV and separated into PBML and PMNL fractions using Ficoll–Paque gradients as described under
Materials and Methods. The DNA and RNA were extracted and analyzed from matched fractions by (A) PCR and (B) RT-PCR, respectively, as
described in the legend for Fig. 1. Positive DNA controls included pRE1, a plasmid containing the relevant region of MCMV DNA (104, 102, 101, and
100 copies).
dent experiments from latently infected or mock-infected PBML were isolated by an alternative technique, the sig-
nal obtained in the PBML fraction was further confirmedmice (21 days p.i.) using the alternative method and three
mice/sample were pooled (three samples/experiment). and shown to not be due to PMNL or some other non-
PBML cell such as endothelial cells contaminating thisThese samples were separated into monocytes and lym-
phocytes based upon staining for the CD11b surface fraction. The possibility of contaminating endothelial
cells was a concern since endothelial cells permissiveantigen. As with other cell fractions, the DNA and RNA
were extracted from the matched fractions and analyzed to HCMV infection have been recently reported to be
circulating in the blood of viremic humans (Grefte et al.,by double PCR and double RT-PCR. As Fig. 5 shows,
no ie-1 DNA signal was detected in the Mac-1-negative 1993; Percivalle et al., 1993). As described under Materi-
als and Methods, the alternative method resulted in ap-(lymphocyte) fractions, but signal was obtained in the
Mac-1-positive (monocyte) fractions. While standard PCR proximately a 5.1-fold increase in the number of cells
and an increase in purity of PBML from the original 94%revealed slight signals for Mac-1-positive fractions (data
not shown), double PCR for ie-1 DNA was utilized to to 99%. While this would result in a predicted 5.1-fold
increase of APRT signal regardless of the presence ofamplify the signal obtained in the Mac-1-positive cells
as well as to ensure a true negative signal in the Mac- latent CMV, the ie-1 signal should increase ca. 5.4-fold
if it were from latently infected PBML or decrease ca.1-negative cells. Negative results for double RT-PCR con-
firmed that DNA detected was not due to an active repli- 3.4-fold if the signal were from contaminating cells. As
shown in Fig. 4, the ie-1 DNA signal increased with thecating infection and was consistent with a persistent/
latent infection. These results indicate that monocytes alternative isolation method (4.4-fold with a 3.7-fold in-
crease in the APRT signal). The increase, althoughwere the cell type harboring the MCMV DNA in the PBML
fraction. slightly less than predicted, indicates the persisting CMV
DNA was harbored in the PBML.
Our findings of MCMV DNA persisting in both PMNLDISCUSSION
and monocytes is in relative agreement with the findings
of Collins et al. (1994) for acute infection. Although theirWe show here that at 21 days p.i. MCMV DNA persists
findings were for stronger association with the mono-in mouse buffy-coat cells and that both monocytes (Mac-
cytes than with the PMNL, these investigators found virus1/ PBML) and PMNL, but not lymphocytes (Mac-10
and viral DNA associated acutely with both cell types.PBML), harbor the MCMV DNA. Highly sensitive and spe-
In the present study the relative number of copies ofcific PCR and RT-PCR using DNA/RNA size-differentiat-
MCMV DNA was one for every 1 1 102 to 6 1 102 cellsing primers were employed to analyze samples of buffy
coat and subpopulations of blood cells from mice. When for both PBML and monocyte fractions. In contrast, the
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gests that cells in the samples tested were not produc-
tively infected.
A second concern is whether the DNA detected in
the peripheral blood represented DNA that is potentially
biologically active. This is one obvious requirement for
latent DNA and it is typically tested by cocultivating po-
tentially latently infected tissue or cells on permissive
tissue culture cells in an attempt to recover reactivated
virus. We have not been able to cocultivate the virus
from peripheral blood (B. M. Mitchell and J. G. Stevens,
unpublished results) and it is well established that HCMV
cannot be recovered in this manner (Jordan, 1983). Al-
though these results are compatible with the hypothesis
that the DNA is not biologically active, it has been shown
that freshly isolated monocytes are difficult to infect with
HCMV and do not replicate virus (Einhorn and Ost, 1984;
Rice et al., 1984). This nonpermissiveness can, at least
in part, be overcome since an increase in the number of
cells permissive to HCMV infection results from extended
culturing of peripheral blood monocytes with and without
treatment of other agents (Ibanez et al., 1991; Lathey and
Spector, 1991; Soderberg et al., 1993). These results,
when combined with the knowledge that the incidence of
transfusion-associated infection is reduced when blood
FIG. 4. Comparison of MCMV ie-1 DNA in PBML fractions of latently
infected mice collected using the original and alternative methods of
isolation. Buffy-coat cells were collected from mock-infected mice and
mice infected for 21 days with MCMV and separated into PBML frac-
tions by either the standard or the alternative method using Ficoll–
Paque gradients as described under Materials and Methods. The DNA
was extracted and analyzed by PCR as described in the legend for
Fig. 1. Positive DNA controls included pRE1, a plasmid containing the
relevant region of MCMV DNA (104 and 102 copies).
inability to detect MCMV DNA in the lymphocyte fraction
using double PCR analysis shows that MCMV DNA must
have been present at less than one copy per 1.7 1 104
cells, strongly indicating that this fraction was truly negative.
Before discussing the results further, it is important to
consider three issues related to the CMV DNA detected.
First, although viral ie-1 RNA could be detected by double
PCR at a sensitivity of less than 10 copies of RNA per
sample, it could be questioned whether the DNA de-
tected in the samples represented DNA associated with
replicating virus. As we detailed earlier (Yuhasz et al., FIG. 5. MCMV ie-1 DNA and RNA in Mac-1/ and Mac-10 PBML
fractions of latently infected mice. PBML cells were collected from the1994), the associated ie-1 RNA in acute infections, in
buffy coat of mice infected with MCMV 21 days p.i., using the alternatereactivated latent infections, and even in low-level persis-
method. The PBML were combined as ‘‘three-mouse pools,’’ stainedtent infections is well within measurable ranges when
with FITC-labeled Mac-1 monoclonal antibody, and separated by FACS
the amount of viral DNA detected in the present experi- into Mac-1/ and Mac-10 fractions. The DNA was extracted and ana-
ments is found. Acute infections and reactivated latent lyzed from matched fractions by double PCR as detailed under Materi-
als and Methods. Primers specific for the MCMV ie-1 gene amplifyinfections display RNA:DNA ratios greater than 1, while
DNA as a 476-bp product. Positive DNA controls for the double PCRratios for low-level persistent infections such as those in
included serial dilutions of pRE1, a plasmid containing the relevantthe lungs range from 0.018 to 0.24 (Yuhasz et al., 1994). In
region of MCMV DNA (105 to 100 copies), while template-free ddH2Othe studies presented here, the RNA levels of all latently served as a negative control. Included as positive and negative controls
infected samples were below levels of detection indicat- for the second PCR reaction in the double PCR analysis were 105
copies of pRE1 and ddH2O, respectively (single PCR).ing an RNA:DNA ratio below 1/10,000. This strongly sug-
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products are depleted of white blood cells (Yeager et al., 1988; Dankner et al., 1990; Gerna et al., 1991; Revello et
al., 1992), Taylor-Wiedeman et al. (1993) found no HCMV1981), suggest that while peripheral blood cells may well
be carriers of latent CMV DNA, additional differentiation DNA in PMNL samples taken from 10 healthy subjects
(7 seropositive; 3 seronegative). These workers couldand/or other signals may be necessary for the DNA to
become active in reactivation. Transfusion-associated detect 10 copies of HCMV DNA, a sensitivity which is at
least 4 orders of magnitude greater than was requiredtransfer of infection in the absence of detectable infec-
tious virus represents additional evidence for a latent for us to detect the MCMV DNA in PMNL fractions. This
difference between our findings and those of Taylor-infection. The possibility of additional differentiation or
signals being required is supported by the work of Taylor- Wiedeman et al. (1993) may be due to differences be-
tween time periods post-acute infection of our samplesWiedemen et al. (1994) who showed that the induction
of endogenous ie-1 and ie-2 HCMV gene expression in and theirs since there is evidence that, at least for
MCMV, the number of latent-positive leukocytes de-monocytes isolated from healthy CMV carriers can result
from cellular differentiation in vitro. From these consider- creases with time (Balthesen et al., 1993) and this may
be related to a differential loss in PMNL and monocytications it seems that the physiological state of involved
cells is critical for virus replication and potential reactiva- populations. Additionally, as discussed below, it is possi-
ble that certain cells in the granulocytic lineage of mice,tion, and although we have not shown that the viral DNA
detected is indeed ‘‘reactivatable,’’ the proper conditions but not humans, continue to harbor latent virus.
The differences between our findings and those offor facilitating this reactivation may not have been em-
ployed. Collins et al. (1993) are surprising; they were not able to
detect latent MCMV DNA extracted from pooled whole-The final concern, and one that may be related to the
second, is the possibility that since monocytes and PMNL blood samples or from pooled PBML or PMNL of mice
104 days after infection. While their analysis was per-both have phagocytic properties, the DNA detected had
been phagocytosed by these cells. Although it cannot be formed at a later time point than ours, others have been
able to detect MCMV DNA in blood leukocytes as lateruled out, we do not favor this alternative, and for the follow-
ing reasons. First, the discussion concerning the impor- as 12 months postinfection (Balthesen et al., 1993). It
may be important to point out that Belthesen et al. (1993)tance of physiological state of leukocytes which was just
presented represents a reasonable explanation for viral inoculated neonates since the age of the animal may
influence the dynamics of the infection as supported byrestriction. Second, the relatively high levels of CMV DNA
detected in the PMNL do not suggest phagocytosis. While other studies (Collins et al., 1993). However, the age of
the mice used in the studies presented here were similarlymphocytes recirculate between the blood, tissue, and
lymph, PMNL do not return to the blood once they have to the age used by Collins et al. (1993). One possible
explanation for the dissimilarity could be the route ofmigrated to other tissues. Because of this, if the MCMV
DNA detected in these studies resulted from phagocytosis, infection. Collins et al. (1993) infected the mice by intra-
peritoneal injection, which requires replication in thethe phagocytosis must have occurred in the circulatory
system. Tests of mouse blood plasma 21 days p.i. for infec- peritoneum before spread to other tissues occurs, and
we infected by tail vein injection. The latter route may betious virus using a standard MEF monolayer plaque assay
(Yuhasz et al., 1994) (sensitivity 1 PFU/0.8 ml of plasma more efficient in seeding multiple organ systems, includ-
ing bone marrow. Since blood leukocytes are only tran-adsorbed) and for viral DNA using PCR (sensitivity 102 cop-
ies/10 ml assayed) were negative for both (Mitchell and siently present in the circulation (Metcalf, 1989), CMV
DNA must be continuously ‘‘seeded’’ into them if a long-Stevens, unpublished results). Inability to detect virus or
viral DNA in blood plasma does not suggest that the CMV term persistence is to occur. Bone marrow is a likely
candidate as the source for these latently infected cells,DNA found was associated with scavenging within the cir-
culatory system. Finally, this alternative seems more un- and this was not tested by Collins et al.
It seems quite possible then, that progenitor bone mar-likely when it is remembered that PMNL and monocytes
spend only a few hours to a few days in the circulation row cells are latently infected, maintain the viral DNA,
and subsequently replicate and transmit the DNA as they(Metcalf, 1989).
Our findings of MCMV DNA in monocytes and its ab- divide and terminally differentiate. Several observations
made by others support this concept. First, Kondo etsence in lymphocytes is consistent with results of Taylor-
Wiedeman et al. (1991) for HCMV, but they differ from the al. (1994) showed that latent HCMV can be detected in
myeloid bone marrow cells (CD14/, CD15/, CD33/) thatfindings involving PMNL (Taylor-Wiedman et al., 1993).
These results also contrast with those of Collins et al. serve as progenitors for both peripheral blood granulo-
cytes and monocytes. It is also known that HCMV infects(1993) who did not detect latent MCMV DNA in either
whole blood or Ficoll–Hypaque-prepared blood frac- CD34/ bone marrow cells (Minton et al., 1994) which are
precursors for both granulocytes and monocytes. Finally,tions. While PMNL have been shown to harbor HCMV in
viremic patients (Rinaldo et al., 1977; Saltzman et al., CD13, a cellular surface molecule on granulocytes,
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Zavattoni, M., Grossi, P., and Milanesi, G. (1991). Monitoring of humanmonocytes, and their bone marrow precursors, has been
cytomegalovirus infections and ganciclovir treatment in heart trans-reported to mediate HCMV infection (Soderberg et al.,
plant recipients by determination of viremia, antigenemia, and DNAe-
1993). Currently, we are separating and analyzing the mia. J. Infect. Dis. 164, 488–498.
bone marrow cells of mice latently infected with MCMV Grefte, A., van der Giessen, M., van Son, W., and The, T. H. (1993).
Circulating cytomegalovirus (CMV)-infected endothelial cells in pa-to determine whether myeloid stem cells do in fact harbor
tients with an active CMV infection. J. Infect. Dis. 167, 270–277.MCMV DNA. Whatever these experiments demonstrate,
Henry, S. C., and Hamilton, J. D. (1993). Detection of murine cytomegalo-it is clear from the present study that in latently infected
virus immediate early 1 transcripts in the spleens of latently infected
mice, MCMV DNA in peripheral blood is detectable only mice. J. Infect. Dis. 167, 950–954.
in monocytes and PMNL. Henson, D., Smith, R. D., and Gehrke, J. (1966). Nonfatal mouse cyto-
megalovirus hepatitis. Am. J. Pathol. 49, 871–888.
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